Novartis Pharmaceuticals

 

Multiple Sclerosis
13:54

Novartis Pharmaceuticals

Evaluating Treatment-Naïve Patient Data and Long-Term Safety Profile of a Preferred RMS Treatment: Expert Insights & Patient Experience

FEATURING Ann Bass
  • April 4, 2025

Novartis Pharmaceuticals

Real Patient & Expert Perspectives on Getting Started on SC B-Cell RMS Therapy

FEATURING Ann Bass
  • April 4, 2025
  • 1

Novartis Pharmaceuticals

Explore Why This SC B-Cell Treatment Is a Top Choice: Pivotal Trial Results Including Tolerability

FEATURING Ann Bass
  • May 6, 2025
  • 1
17:13

Novartis Pharmaceuticals

Hear Expert Perspectives on the Intentional Design of this B-cell RMS Therapy

FEATURING Robert Shin, Regina Berkovich, Stephen Hauser, Patricia Coyle
  • May 7, 2025
11:14

Novartis Pharmaceuticals

Choosing a SC B-Cell Therapy With Your Patients With RMS

FEATURING Jasmin Patel, Barry Hendin, Jean Bakke-Cain
  • May 7, 2025